Shares in Qiagen hit a 52-week high of $15.58 earlier this week before closing at $14.91 on Tuesday, up 8.4 percent for the tracking period. Shares in Qiagen, which led gains among all issues in the BCW Index, have risen 32.5 percent over the past month.

Meanwhile, Bio-Rad shares dropped 11.9 percent for the week, leading all decliners. Last week, the firm reported that its fourth-quarter profit and revenue were hit by costs associated with a legal dispute (see feature).

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.